{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:41:24Z","timestamp":1759344084987,"version":"build-2065373602"},"reference-count":14,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"abstract":"<jats:p>ABSTRACT  Background:  Erythema nodosum leprosum (ENL) is an immunological inflammatory reaction requiring precise management. Recalcitrant cases, their refractoriness to conventional therapy, and the adverse effects of standard treatments underline the need to explore alternative therapeutic options.  Methods:  We conducted a retrospective study of five patients treated with secukinumab between January 2023 and January 2025.  Results:  Patients showed clinical improvement with a reduced ENL frequency, neuritis relief, and corticosteroid sparing.  Conclusions:  Secukinumab appears to be a promising corticosteroid-sparing option for ENL, with a favorable safety profile. Further studies are required to confirm the efficacy and long-term safety of this treatment regimen.<\/jats:p>","DOI":"10.1590\/0037-8682-0118-2025","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:19:10Z","timestamp":1759342750000},"source":"Crossref","is-referenced-by-count":0,"title":["Managing leprosy reactions with secukinumab: Insights from a case series"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5465-5462","authenticated-orcid":false,"given":"Luciana Vilela","family":"Gomide","sequence":"first","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil; Universidade Federal de Goi\u00e1s,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9752-377X","authenticated-orcid":false,"given":"Jo\u00e3o Paulo Turri","family":"Brufatto","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7339-3026","authenticated-orcid":false,"given":"Thiago Jess\u00e9","family":"Kucarz","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7901-2351","authenticated-orcid":false,"given":"Paulo Eduardo Neves Ferreira","family":"Velho","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-4570","authenticated-orcid":false,"given":"Andr\u00e9a Fernandes Eloy da Costa","family":"Fran\u00e7a","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","series-title":"Leprosy - data and statistics","year":"2025"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2019.10.138","article-title":"Leprosy: treatment and management of complications","volume":"83","author":"Maymone MBC","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref3","first-page":"132","article-title":"Can etanercept be an option in management of recurrent steroid dependent erythema nodosum leprosum?","volume":"88","author":"Sahani MK","year":"2017","journal-title":"Lepr Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.25259\/IJDVL_726_20","article-title":"Ustekinumab in erythema nodosum leprosum: a retrospective study of six patients","volume":"88","author":"Sharma R","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","article-title":"Long-term systemic corticosteroid exposure: a systematic literature review","volume":"39","author":"Rice JB","year":"2017","journal-title":"Clin Ther"},{"key":"ref6","article-title":"Effective management of severe chronic erythema nodosum leprosum in adolescent patient using ustekinumab: a case report","volume":"38","author":"Meneget L","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","first-page":"661","article-title":"Comparison of serum levels of interleukin 17 and interleukin 6 in leprosy patients with and without lepra reaction: a cross-sectional analytical study from Central India","volume":"68","author":"Choudhary R","year":"2023","journal-title":"J Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0336-2021","article-title":"Significant clinical improvements in refractory leprosy-related reactions with the modulation of T helper 1 (Th1) and T helper 17 (Th17) immune pathways","volume":"54","author":"Kurizky PS","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/ijmy.ijmy_174_18","article-title":"A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in Central India","volume":"8","author":"Wankhade VH","year":"2019","journal-title":"Int J Mycobacteriol"},{"key":"ref10","first-page":"557","article-title":"Treatment of recurrent erythema nodosum leprosum with infliximab","volume":"354","author":"Faber WR","year":"2006","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijmyco.2016.02.002","article-title":"Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor etanercept","volume":"5","author":"Chowdhry S","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2018.07.005","article-title":"\u03b3\u03b4 T cells are associated with inflammation and immunopathogenesis of leprosy reactions","volume":"205","author":"Saini C","year":"2018","journal-title":"Immunol Lett"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2016.03.024","article-title":"Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis","volume":"75","author":"Van de Kerkhof PC","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjd.18233","article-title":"Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases","volume":"182","author":"Narang T","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0037-86822025000100705&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:19:13Z","timestamp":1759342753000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822025000100705&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":14,"alternative-id":["S0037-86822025000100705"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0118-2025","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e0118-2025"}}